Dr. Moulay Mustapha Ennaji, Professor in Virology and Oncology at the University of Casablanca and Director of the Quality and Medical Biotechnologies Team at Laboratory of Virology Microbiology, Hassan II University Mohammedia of Casablanca, Morocco He is currently a Professor in Virology and Oncology at the University of Casablanca, and since 2010, he has been the Director of the Quality and Medical Biotechnologies Team at the Laboratory of Virology Microbiology, Quality, Biotechnologies. He received a MSc in 1986 and a PhD in virology in 1993 from Armand Frappier Institute, University of Quebec (Canada). He has published dozens of journals articles and is an editorial board member of the journal, Infectious Agents and Cancer. Throughout his career, Dr. Ennaji has been rewarded several awards. At present, he is the vice president of the three Moroccan societies of Biosafety, Cancer, and Microbiology.

• 1. Gene suppressor and oncogenes2. Implication of growth factor's genes in genitourinary cancers3. Cytokines genes alterations4. Proteomic analysis5. Genetic diagnostics and prognostic biomarkers6. Exosomes as diagnostic and prognostic tool7. Metabolism defects8. Clinical genomic relevance9. Recent advances of immunotherapy10. Modern therapeutic targets

Dr. Moulay Mustapha Ennaji, Professor in Virology and Oncology at the University of Casablanca and Director of the Quality and Medical Biotechnologies Team at Laboratory of Virology Microbiology, Hassan II University Mohammedia of Casablanca, Morocco He is currently a Professor in Virology and Oncology at the University of Casablanca, and since 2010, he has been the Director of the Quality and Medical Biotechnologies Team at the Laboratory of Virology Microbiology, Quality, Biotechnologies. He received a MSc in 1986 and a PhD in virology in 1993 from Armand Frappier Institute, University of Quebec (Canada). He has published dozens of journals articles and is an editorial board member of the journal, Infectious Agents and Cancer. Throughout his career, Dr. Ennaji has been rewarded several awards. At present, he is the vice president of the three Moroccan societies of Biosafety, Cancer, and Microbiology.

• 1. Gene suppressor and oncogenes2. Implication of growth factor's genes in genitourinary cancers3. Cytokines genes alterations4. Proteomic analysis5. Genetic diagnostics and prognostic biomarkers6. Exosomes as diagnostic and prognostic tool7. Metabolism defects8. Clinical genomic relevance9. Recent advances of immunotherapy10. Modern therapeutic targets

Dr. Moulay Mustapha Ennaji, Professor in Virology and Oncology at the University of Casablanca and Director of the Quality and Medical Biotechnologies Team at Laboratory of Virology Microbiology, Hassan II University Mohammedia of Casablanca, Morocco He is currently a Professor in Virology and Oncology at the University of Casablanca, and since 2010, he has been the Director of the Quality and Medical Biotechnologies Team at the Laboratory of Virology Microbiology, Quality, Biotechnologies. He received a MSc in 1986 and a PhD in virology in 1993 from Armand Frappier Institute, University of Quebec (Canada). He has published dozens of journals articles and is an editorial board member of the journal, Infectious Agents and Cancer. Throughout his career, Dr. Ennaji has been rewarded several awards. At present, he is the vice president of the three Moroccan societies of Biosafety, Cancer, and Microbiology.

• 1. Gene suppressor and oncogenes2. Implication of growth factor's genes in genitourinary cancers3. Cytokines genes alterations4. Proteomic analysis5. Genetic diagnostics and prognostic biomarkers6. Exosomes as diagnostic and prognostic tool7. Metabolism defects8. Clinical genomic relevance9. Recent advances of immunotherapy10. Modern therapeutic targets